BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33725824)

  • 1. Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA).
    Heshmatzadeh Behzadi A; Amoozgar B; Jain S; Velasco N; Zahid U; Abbasi H; Alasadi L; Prince MR
    Medicine (Baltimore); 2021 Mar; 100(10):e24603. PubMed ID: 33725824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency.
    Ye Z; Lu H; Su Q; Xian X; Li L
    Oncotarget; 2017 Nov; 8(60):102521-102530. PubMed ID: 29254267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Trimetazidine in the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Contrast Coronary Intervention: A Systematic Review and Meta-Analysis (PRISMA).
    Nair T; Ray S; George J; Pande A
    J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610916
    [No Abstract]   [Full Text] [Related]  

  • 4. Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
    Jones DA; Beirne AM; Kelham M; Wynne L; Andiapen M; Rathod KS; Parakaw T; Adams J; Learoyd A; Khan K; Godec T; Wright P; Antoniou S; Wragg A; Yaqoob M; Mathur A; Ahluwalia A
    Eur Heart J; 2024 May; 45(18):1647-1658. PubMed ID: 38513060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NITRATE-CIN Study: Protocol of a Randomized (1:1) Single-Center, UK, Double-Blind Placebo-Controlled Trial Testing the Effect of Inorganic Nitrate on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography for Acute Coronary Syndromes.
    Beirne AM; Mitchelmore O; Palma S; Andiapen M; Rathod KS; Hammond V; Bellin A; Cooper J; Wright P; Antoniou S; Yaqoob MM; Naci H; Mathur A; Ahluwalia A; Jones DA
    J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):303-309. PubMed ID: 33764198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SGLT-2 inhibitors and prevention of contrast-induced nephropathy in patients with diabetes undergoing coronary angiography and percutaneous coronary interventions: systematic review and meta-analysis.
    Meregildo-Rodriguez ED; Asmat-Rubio MG; Vásquez-Tirado GA
    Front Endocrinol (Lausanne); 2023; 14():1307715. PubMed ID: 38179307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis.
    Ye Z; Lu H; Guo W; Dai W; Li H; Yang H; Li L
    Medicine (Baltimore); 2016 Nov; 95(46):e5306. PubMed ID: 27861357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis.
    Li JX; Jin EZ; Yu LH; Li Y; Liu NN; Dong YM; Li X; Li XQ
    Exp Ther Med; 2017 Aug; 14(2):1568-1576. PubMed ID: 28810622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Kidney Injury in Patients Undergoing Both Right and Left Heart Catheterization with Coronary Angiography Vs Right Heart Catheterization Only.
    Min A; Roy S; Chaturvedi A; Choxi R; Wasilewski M; Arora P; Perera RA; Jovin IS
    Am J Med; 2024 May; 137(5):442-448. PubMed ID: 38307150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization.
    Kumar A; Bhawani G; Kumari N; Murthy KS; Lalwani V; Raju ChN
    J Clin Diagn Res; 2014 Dec; 8(12):HC03-7. PubMed ID: 25653965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast nephropathy.
    Rezkalla SH
    Clin Med Res; 2003 Oct; 1(4):301-4. PubMed ID: 15931323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review for prevention of cisplatin-induced nephrotoxicity using different hydration protocols and meta-analysis for magnesium hydrate supplementation.
    Li J; Wu Y; Chen C; Zhang W; Yue L; Liu T
    Clin Exp Nephrol; 2024 Jan; 28(1):1-12. PubMed ID: 37530867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of trimetazidine in healthy individuals: a systematic review.
    Bezuglov E; Zholinsky A; Shoshorina M; Waśkiewicz Z; Emanov A; Morgans R; Bertholz V; Zelenskaya V; Lazarev A; Sokolskaya M; Talibov O
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(14):6882-6889. PubMed ID: 37522701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction Note: New insight of the efficacy trimetazidine in patients with peripheral arterial disease: a meta-analysis.
    Pramana KAAP; Cahyani NGAMSD; Pintaningrum Y; Rahmat B
    Egypt Heart J; 2024 May; 76(1):57. PubMed ID: 38758430
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of short-term moderate or high-dose statin therapy for the prevention of contrast-induced nephropathy in high-risk patients with chronic kidney disease: systematic review and meta-analysis.
    Zhou YL; Chen LQ; Du XG
    Clinics (Sao Paulo); 2021; 76():e1876. PubMed ID: 33787670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative risk for intracranial hemorrhage related to new oral anticoagulants: A network meta-analysis.
    Ma T; Liu C; Jiang T; Qin H; Wu R; Zhou P
    Medicine (Baltimore); 2021 Mar; 100(12):e24522. PubMed ID: 33761634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
    Takahashi K; Nishijima K; Yamaguchi M; Matsumoto K; Sugai S; Enomoto T
    J Med Case Rep; 2021 Mar; 15(1):126. PubMed ID: 33743806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow Coronary Flow: Pathophysiology, Clinical Implications, and Therapeutic Management.
    Chalikias G; Tziakas D
    Angiology; 2021 Oct; 72(9):808-818. PubMed ID: 33779300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative Medical Optimization of Symptomatic Benign Prostatic Hyperplasia Is an Economically Justified Infection Prevention Strategy in Total Joint Arthroplasty.
    Moverman MA; Bruha MJ; Pagani NR; Puzzitiello RN; Menendez ME; Barnes CL
    J Arthroplasty; 2021 Jul; 36(7):2551-2557. PubMed ID: 33775467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid Free Ureteroscopy: What is the True Failure Rate?
    Lee MS; Assmus M; Agarwal D; Rivera ME; Large T; Krambeck AE
    Urology; 2021 Aug; 154():89-95. PubMed ID: 33774043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.